Biotech Values

[mcbio]

GT3 patients will also have the option to be treated with Sofosbuvir/PegRiba until a more viable oral combination is developed.

What is your prediction of what will be the first viable oral combo for GT3? Is it presumably going to include some, or perhaps all, drug components that aren't even in the clinic right now? Presumably a nuke is still going to be the backbone, whether that's sofosbuvir or some follow-on uridine nuke.